| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $1.4M | -92.8% |
| SG&A Expense | $12.7M | +16.2% |
| Operating Income | -$15.0M | -719.0% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$16.9M | -612.8% |
| Income Tax | $0 | -100.0% |
| Net Income | -$16.9M | -555.1% |
| EPS (Basic) | -$2.11 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $816K | -90.5% |
| Current Assets | $2.0M | -79.9% |
| Total Assets | $11.6M | -50.4% |
| Current Liabilities | $2.5M | +53.1% |
| Total Liabilities | $8.5M | +1.7% |
| Stockholders' Equity | $3.0M | -79.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | +71.0% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$1.1M | -123.0% |
| Financing Cash Flow | $3.7M | +218.3% |
| Free Cash Flow | -$10.4M | +71.0% |
| -276.8% |
| EPS (Diluted) | -$2.11 | -276.8% |